Phase 3 Boosting Study for the SARS-CoV-2 rS Variant Vaccines
Study sponsor: Novavax
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-07-17Actual
Enrollment · participants1340Actual
Source updated2024-04-23Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.